Chapter 6 224 Table S1 (part 1). Continued Diagnosis Driver mutation (TISSUE) EGFR T790M detected in tumor tissue Reason for pleurocentesis NKI-17 NSCLC KRAS therapeutic NKI-18 NSCLC EGFR exon 19 del EGFR T790M therapeutic NKI-19 NSCLC EGFR exon 19 del therapeutic NKI-20 NSCLC EGFR exon 19 del therapeutic NKI-21 NSCLC EGFR L858R EGFR T790M therapeutic NKI-22 NSCLC KRAS therapeutic NKI-23 appendiceal carcinoma KRAS therapeutic NKI-24 NSCLC KRAS therapeutic NKI-25 NSCLC KRAS diagnostic NKI-26 NSCLC EGFR G719X diagnostic NKI-27 NSCLC EGFR exon 19 del diagnostic NKI-28 colon carcinoma KRAS therapeutic NKI-29 NSCLC EGFR exon 19 del diagnostic NKI-30 NSCLC EGFR exon 19 del therapeutic NKI-31 NSCLC EGFR exon 19 del EGFR T790M therapeutic NKI-32 NSCLC KRAS therapeutic NKI-33 NSCLC KRAS diagnostic NKI-34 NSCLC EGFR exon 19 del therapeutic NKI-35 colon carcinoma KRAS therapeutic
RkJQdWJsaXNoZXIy MTk4NDMw